MENU
Thinkwell

see more

Dodoma
Jakarta
Hanoi
Amman
Nairobi
Port-au-Prince
Monrovia
Cairo
Lusaka
Maputo
Dar Es Salaam
Antananarivo
Karachi
Dhaka
Manila
Thinkwell
3minute
read

What does it cost to implement a measles-rubella immunization campaign? New evidence from India and Sierra Leone

17 September 2021

A vaccination campaign requires significant resources over a short period of time. Unlike with routine immunization programs, where resource allocations can be fine-tuned over time, a campaign is a one-off opportunity to make an impact. Inadequate funding or late disbursements can derail a campaign completely, and a low-impact campaign may be a considerable waste of resources. Nevertheless, the cost of delivering immunization through campaigns is not well understood. To address this gap, ThinkWell estimated the cost of two measles-rubella (MR) catch-up campaigns in Sierra Leone and India.

In India, the government undertook a large-scale phased campaign from 2017 to 2020, vaccinating over 324 million children aged between 9 months and 15 years in 34 Indian states and Union Territories. In Sierra Leone, a seven day campaign was conducted in June 2019. Just under three million MR vaccines were delivered, alongside oral polio vaccines (OPV) nationwide, and vitamin A supplements and deworming tablets (albendazole) in half of the country’s districts.

Both studies estimated the full financial and economic costs of the campaign in Sierra Leone and the financial delivery costs in three states in India (Assam, Gujarat, Himachal Pradesh) and the full economic costs in one state (Uttar Pradesh). The study in Sierra Leone was the first to generate cost evidence for co-delivery campaigns, which are likely to become more common.

Key findings of the studies included:

  • The financial delivery cost per dose ranged from US$0.16 to US$0.34 across the states in India and was US$0.31 during the integrated campaign in Sierra Leone.
  • Per diems and incentives for staff were the main cost drivers of the MR campaigns in both Sierra Leone and India. Service delivery was a cost driver for both campaigns, followed by training and social mobilization in Sierra Leone and supervision and record keeping in India.
  • The economic delivery costs were estimated at US$0.69 per dose in Sierra Leone and US$0.87 in Uttar Pradesh, mainly driven by the value of paid and unpaid labor.
  • In Sierra Leone, we found that financial cost efficiencies could be achieved through integration. However, the opportunity costs of labor were higher in districts that co-delivered both vaccines and nutrition interventions, indicating the higher burden that co-delivery campaigns place on the existing health system.
  • In India, the delivery cost was higher than the government pre-fixed budget per child for the MR campaign. While this suggests an insufficient budget, the study also found underutilization of the MR budget in two states and use of other sources of funding for the campaign. This indicates a potential need for more flexibility around the use of campaign budgets in Indian states.

The cost estimates from both studies can be used for future planning and budgeting of campaigns in India, Sierra Leone and other countries. To read the full study reports, please click here for India and here for Sierra Leone. These studies were a part of the Immunization Costing Action Network (ICAN), a project supported by the Bill & Melinda Gates Foundation, and helped inform the development of methodological guidance on costing immunization campaigns.

Designed by BothAssociates   /  Photo Credits